Sponsor

Krankenhaus Nordwest GmbH

Germany Steinbacher Hohl 2-26, Praunheim, 60488 Frankfurt, Germany

About the sponsor

Clinical research activity is centered on resectable diffuse type gastric adenocarcinoma and gastroesophageal junction Type II/III adenocarcinoma, with attention to patients undergoing curative-intent treatment.

Diffuse type gastric cancer
Gastroesophageal junction tumors
Resectable adenocarcinoma

The sponsor's research interests in this area reflect a focus on disease control and outcomes relevant to surgical oncology and upper gastrointestinal malignancies.

About Specializations

Krankenhaus Nordwest GmbH runs clinical trials in conditions such as Adenocarcinoma gastric, Oesophageal adenocarcinoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

1 clinical trial

Adenocarcinoma gastric+1

Recruiting

Registered drugNo placebo

Study on the Effectiveness of Oxaliplatin, Docetaxel, and Fluorouracil in Patients with Resectable Gastric and Gastroesophageal Junction Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Calcium Folinate
Sponsor:Krankenhaus Nordwest GmbH

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →